1Moran JL,Siegel D,Sun XM,et al.Induction of apoptosis by remoxipride metabolites in HL-60 and CD34+/CD19-human bone marrow progenitor cells.Molecular Pharmacol ,1996,50:610-615.
2Wasserman TH,Brizel DM.Has the outlook improved for amifostine as a clinical radioprotector.Radiother Oncol,2001,60:334-336.
3McGuinness SM,Johansson R,Lundstrom J,et al.Induction of apoptosis by remoxipride metabolites in HL-60 and CD34+/CD19- human bone marrow progenitor cells:potential relevance to remoxipride-induced aplastic anemia.Chem Biol Interact,1999,121:253-265.
4Smith MT.Overview of benzene-induced aplastic anaemia.Eur J Haematol,1996,60 Suppl:107-110.
5List AF,Heaton R,Glinsmann-Gibson B,et al.Amifostine stimulates formation of multipotent and erythroid bone marrow progenitors.Leukemia,1998,12:1596-1602.
6Jahnukainen K,Hou M,Parvinen M,et al.Stage-specific inhibition of deoxyribonucleic acid synthesis and induction of apoptosis by antracyclines in cultured rat spermatogenic cells.Biol Reprod,2000,63:482-487.
2List AF,Brasfield F,Heaton R,et al.Stimulation of hamatopoiesis by amifostine in patients with myelodysplastic syndrome[J].Blood,1997,90:3364-3369.
3Viniou N,Terpos E,Galanopoulos A,et al.Treatment of anemia in low-risk myelodysplastic syndromes with amifostine.In vitro testing of response[J].Ann Hematol,2002,81:182-186.
4Tefferi A,Elliott MA,Steensma DP,et al.Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome[J].Leuk Res,2001,25:183-185.
5Bowen DT,Denzlinger C,Brugger W,et al.Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients[J].Br J Haematol,1998,103:785-787.
6Grossi A,Musto P,Santini V,et al.Combined therapy with amifostine plus erythropoietin for the treatment of myelodysplastic syndromes[J].Haematologica,2002,87:322-323.
7Musch E,Malek M,Chrissafidou A.Amifostine plus erythropoietin in a patient with low-risk myelodysplastic syndrome[J].Ann Hematol,2003,82:244-246.
8Tsiara SN,Kapsali HD,Panteli K,et al.Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes[J].J Exp Clin Cancer Res,2001,20:35-38.
9Neumeister P,Jaeger G,Eibl M,et al.Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome[J].Leuk Lymphoma,2001,40:345-349.
10Grossi A,Fabbri A,Santini V,et al.Amifostine in the treatment of low-risk myelodysplastic syndromes[J].Haematologica,2000,85:367-371.
